GMAB

Genmab (GMAB) Investor Questions

Genmab (GMAB) investor questions: stock forecasts, price data, dividends, earnings dates, valuation and risk, with missing data clearly identified.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Genmab
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
80
Annual revenue
$3.72B
Annual net income
$963.00M
Annual free cash flow
$1.15B

Genmab (GMAB) Investor Questions research

Genmab trades under the ticker GMAB. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review GMAB through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.

What is Genmab (GMAB) stock?

Genmab trades under ticker GMAB. Its recorded sector is Healthcare. Its industry is Biotechnology.

What does the GMAB stock forecast mean?

BTI's forecast summarizes available short-term and long-term research scores for GMAB. These scores are not price targets, analyst consensus or probabilities of a positive return. Compare the Forecast, Earnings and Valuation pages before interpreting the outlook.

Where can I find the GMAB stock price today?

Check the GMAB quote and chart in the research workspace, including currency, trading session and quote timestamp. The research-record update time on this page is not a live quote timestamp.

Does GMAB pay dividends?

Dividend yield is not supplied in this GMAB research record. Missing data does not establish that Genmab does not pay dividends. Check the company's dividend announcements for declared amounts and dates.

When does GMAB report earnings?

The available earnings record lists 2026-08-06 for GMAB. This stored date may be historical; it is not confirmation of the next announcement. Check Genmab's investor-relations calendar for the current schedule; estimated dates can change.

How can I assess GMAB's valuation and risk?

Compare Genmab's financial results, cash flow, debt and valuation assumptions with its operating risks and competitors. The Financials, Valuation and Statistics pages provide the available figures. A BTI score is a research input, not a personalized recommendation.